Both Skyrizi and its cousin Rinvoq have landed in the annual top three, in varying positions, since 2022. That was once again the case in 2025, when Skyrizi retained its place at the top and Rinvoq ...
After a 2024 in which AbbVie’s Skyrizi boasted the highest TV drug ad spending outlay on seven of our monthly roundups—and took second place in four more—the immunology med has seen that dominance ...
eSpeaks’ Corey Noles talks with Rob Israch, President of Tipalti, about what it means to lead with Global-First Finance and how companies can build scalable, compliant operations in an increasingly ...
BELLEVUE, Wash.—Despite ongoing worries about the economy, new data from iSpot shows that national linear advertising revenue recorded a 4.2% increase in Q3 2025 versus a year earlier to $8.77 billion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback